Berlin / Frankfurt, September 4, 2007 - In preparation for a planned exchange listing, MagForce Nanotechnologies AG, a German investment holding of Nanostart AG, has successfully completed a capital increase with net proceeds in the single-digit millions of euros. Shares of MagForce were offered at a price of € 47 in a private placement available exclusively to institutional investors. The transaction was executed by Steubing AG, a Frankfurt-based investment bank.
"With this additional capital, we will be able to push forward more aggressively, above all with our clinical studies now in progress, as well as studies to investigate new indications. This should help to accelerate the timetable for European regulatory approval and to broaden its scope. We would also like to expand our research and development program and in particular to further develop Nanotherm®, our iron oxide particle for nanotech-based cancer therapy," said Dr. Uwe Maschek, CEO of MagForce Nanotechnologies AG.
About Nanostart:
Nanostart AG is Europe’s leading nanotechnology investment company, with headquarters in Frankfurt, Germany. The company is organized into two divisions: the Portfolio Division, which manages its own investment holdings; and the Financial Services Division, which advises financial service providers on investing in the nanotechnology sector.
About MagForce Nanotechnologies:
MagForce Nanotechnologies AG is the world’s leading company in the area of nanotechnology-based cancer treatment. Its patented therapy allows the targeted destruction of tumors using magnetic nanoparticles. MagForce’s nanotechnology represents a revolutionary approach to the future successful treatment of solid tumors.
DISCLAIMER:
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within the United States of America, Canada, Australia or Japan.
Media contact:
Nanostart AG
Public Relations
Dr. Hans Joachim Dürr
Goethestrasse 26-28
60313 Frankfurt
Germany
phone: +49 (0)69-21 93 96 111
fax: +49 (0)69-21 93 96 122
e-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
